journal cover

Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis

Current Opinion in Rheumatology

Mar 2, 2010

Michael G Feely, J R O'Dell

Abstract

The present review will focus on the role of conventional disease-modifying antirheumatic drugs (DMARDs) in the current management of rheumatoid arthritis (RA). Over the past several decades, the treatment of RA has been revolutionized, not only by the development of highly effective bi...read more

Mentioned in this Paper

Antirheumatic Drugs, Disease-Modifying
Endpoint Determination
Cost Effectiveness
Rheumatoid Arthritis
Cancer Remission
Remission Induction
Rheumatology Specialty
Drug Costs
Biological Factors
Paper Details
References
  • References37
  • Citations8
1234
  • References37
  • Citations8
1

Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis

Current Opinion in Rheumatology

Mar 2, 2010

Michael G Feely, J R O'Dell

PMID: 20190639

DOI: 10.1097/bor.0b013e3283383f87

Abstract

The present review will focus on the role of conventional disease-modifying antirheumatic drugs (DMARDs) in the current management of rheumatoid arthritis (RA). Over the past several decades, the treatment of RA has been revolutionized, not only by the development of highly effective bi...read more

Mentioned in this Paper

Antirheumatic Drugs, Disease-Modifying
Endpoint Determination
Cost Effectiveness
Rheumatoid Arthritis
Cancer Remission
Remission Induction
Rheumatology Specialty
Drug Costs
Biological Factors

Related Papers

Paper Details
References
  • References37
  • Citations8
1234
  • References37
  • Citations8
1
/papers/update-on-the-use-of-conventional-disease-modifyin/20190639